References
Golfieri R, Bezzi M, Verset G. Retrospective European multicentric evaluation of selective transarterial chemoembolisation with and without balloon-occlusion in patients with hepatocellular carcinoma: a propensity score matched analysis. Cardiovasc Interv Radiol. 2021. https://doi.org/10.1007/s00270-021-02805-5.
Gardini AC, Tamburini E, Iñarrairaegui M, Frassineti GL, Sangro B. Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials. Onco Targets Ther. 2018;11:7315–21.
Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim T-Y, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382:1894–905.
van Roekel C, van den Hoven AF, Bastiaannet R, Bruijnen RCG, Braat AJAT, de Keizer B, et al. Use of an anti-reflux catheter to improve tumor targeting for holmium-166 radioembolization—a prospective, within-patient randomized study. Eur J Nucl Med Mol Imaging. European Journal of Nuclear Medicine and Molecular Imaging; 2020;166.
Funding
This study was not supported by any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
MS has received a speaker honorarium from BTG and Terumo. The Department of Radiology and Nuclear Medicine of the UMC Utrecht receives royalties from Quirem Medical and research support from Boston Scientific, Terumo, and Quirem Medical.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
For this type of study, informed consent is not required.
Consent for Publication
For this type of study, consent for publication is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Smits, M.L.J. Innovating TACE to Keep Up with the Rapidly Changing Field of Oncology. Cardiovasc Intervent Radiol 44, 1681–1682 (2021). https://doi.org/10.1007/s00270-021-02823-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-021-02823-3